What are the characteristics of cyclosporiasis, including comparison to cryptosporidiosis and isosporiasis, potential complications, and incubation period?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2025 • View editorial policy

From the Guidelines

Cyclosporiasis is a protozoan infection characterized by watery diarrhea, loss of appetite, weight loss, abdominal bloating and cramping, increased flatus, nausea, fatigue, and low-grade fever.

Comparison to Other Infections

  • Compared to cryptosporidiosis and isosporiasis, cyclosporiasis has similar symptoms, but the severity and duration of the illness can vary.
  • Cryptosporidiosis is more likely to be severe, chronic, or relapsing in immunocompromised individuals, particularly those with impaired cell-mediated immunity.
  • Isosporiasis can also cause chronic diarrhea in immunocompromised patients, but it is less common than cryptosporidiosis.

Potential Complications

  • Cyclosporiasis can lead to malabsorption, weight loss, and dehydration if left untreated or if treatment is delayed.
  • Immunocompromised individuals, such as those with HIV/AIDS or cancer, are at higher risk of developing severe or chronic cyclosporiasis.

Incubation Period

  • The incubation period of cyclosporiasis is typically 1-14 days, with a median of 7 days 1.

Treatment

  • The treatment of choice for cyclosporiasis is trimethoprim-sulfamethoxazole (TMP-SMZ) 160 mg/800 mg twice daily for 7 days 2.
  • Alternative treatments, such as ciprofloxacin, may be used in patients who are intolerant to TMP-SMZ.

Diagnosis

  • Diagnosis of cyclosporiasis is typically made by microscopic examination of stool samples for the presence of Cyclospora oocysts 3.
  • Multipathogen nucleic acid amplification tests can also be used to detect Cyclospora and other enteric pathogens.

From the Research

Characteristics of Cyclosporiasis

  • Cyclosporiasis is an emerging enteric coccidian parasitic disease worldwide, caused by the parasite Cyclospora cayetanensis 4.
  • The disease can cause protracting and relapsing gastroenteritis, and has been linked to huge and complicated travel- and food-related outbreaks worldwide 5.
  • Cyclospora cayetanensis can infect both immunocompetent and immunocompromised persons, with a higher prevalence in immunocompromised patients 4.
  • The median age of patients with cyclosporiasis is 38.5 years, with males outnumbering females 4.

Comparison to Cryptosporidiosis and Isosporiasis

  • Cyclosporiasis, cryptosporidiosis, and isosporiasis are all caused by intestinal spore-forming protozoa, and have similar epidemiology, disease pathogenesis, clinical manifestations, diagnosis, and treatment 6.
  • All three diseases can cause diarrhea, intestinal inflammation, and disordered architecture, and can be transmitted through contaminated water or food 7, 6.
  • However, cyclosporiasis has a longer incubation period and more recurring symptoms compared to cryptosporidiosis and isosporiasis 8.

Potential Complications

  • Cyclosporiasis can cause severe diarrhea, intestinal injury, and prolonged diarrhea, especially in immunocompromised patients 4, 6.
  • The disease can also cause malabsorption, and can lead to significant morbidity and mortality if left untreated 6.
  • Coinfection with other pathogens, such as Cryptosporidium spp., can also occur 4.

Incubation Period

  • The incubation period of cyclosporiasis is typically around 8 days, with a range of 1-14 days 8.
  • The disease can have a characteristic waxing and waning course, with recurring symptoms in nearly 72% of patients 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.